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Conversion of mild cognitive impairment
patients in Alzheimer’s disease: prognostic




Introduction: The increase in electroencephalogram (EEG) alpha3/alpha2 frequency power ratio has been
demonstrated as a biomarker characteristic of subjects with mild cognitive impairment (MCI) who will develop
Alzheimer’s disease (AD).
Methods: Seventy-four adult subjects with MCI underwent clinical and neuropsychological evaluation, EEG
recording, and high-resolution 3D magnetic resonance imaging (MRI). This group has been evaluated after a
three years follow-up. Twenty-seven of these subjects underwent perfusion single-photon emission computed
tomography (SPECT) evaluation also. Increasing alpha3/alpha2 power ratio, was computed for each subject.
Differences in EEG markers, cortical thickness, brain perfusion among the groups were estimated.
Results: In the higher alpha3/alpha2 frequency power ratio group, greater memory impairment was correlated
with greater cortical atrophy and lower perfusional rate in the temporo-parietal cortex. After a follow-up of three
years, these patients converted in AD.
Conclusion: High EEG upper/low alpha power ratio was associated with cortical thinning and lower perfusion in
the temporo-parietal lobe. Moreover, atrophy and lower perfusion rate were both significantly correlated with
memory impairment in MCI subjects. The increase of EEG upper/low alpha frequency power ratio could be useful
for identifying individuals at risk for progression to AD dementia and may be of value in the clinical context.
Introduction
Mild cognitive impairment (MCI) commonly represents
the at-risk state of developing dementia. Therefore, there
is a need to develop early biomarkers that allow identifica-
tion of subjects who could develop the disease and would
be useful for early diagnosis and effective prevention ther-
apies. The identification and validation of biomarkers for
diagnosing, monitoring progression, and predicting the
onset of Alzheimer’s disease (AD) have been a main focus
of AD research in the past ten years. In line with recently
published research criteria, it is becoming clear that the
integration of different biomarkers is a milestone for a cor-
rect and early diagnosis of AD [1]. To date, the most stud-
ied and validated biomarkers are Abeta42 and tau protein
in the cerebrospinal fluid (CSF), glucose hypometabolism
measured by fluorodeoxyglucose positron emission tom-
ography (18F-FDG PET), atrophy of hippocampal volume
(HV) on magnetic resonance imaging (MRI), and brain
amyloid deposition measured by amyloid imaging with
PET [2]. Recent MRI studies have demonstrated that a
large neural network is altered in subjects with prodromal
AD [3]. In particular, subjects with cognitive decline show
early atrophy and loss of gray matter in cortical-specific
brain areas including precuneus, hippocampal, medial
temporal, and parietal lobes [4, 5]. In the conceptual frameCorrespondence: davide.moretti@afar.it
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of the integration of biomarkers for an early and highly
predictive diagnosis, the electroencephalogram (EEG)
could be a reliable tool [6]. Indeed, it is widely accepted that
the cerebral EEG rhythms reflect the underlying brain net-
work activity [7]. Therefore, modifications in EEG rhythms
could be an early sign of AD. In particular, the study of
alpha rhythm seems to be a very suitable tool to detect the
relationship between structural and functional brain net-
works [8]. Previous studies have convincingly demonstrated
that there are thalamo-cortical and cortico-cortical
components that interact in the generation of cortical
alpha rhythms [6]. Recently, it has been demonstrated
that the increase of high alpha relative to low alpha
power is both a reliable EEG marker of hippocampal at-
rophy [9] and predictive of conversion of patients with
MCI to AD, but not to non-AD dementia [10]. On the
other hand, subjects with higher alpha3/alpha2 frequency
power ratios showed a constant trend toward a lower per-
fusion than the low alpha3/alpha2 group associated with
an increase of theta frequency power [11, 12].
In this study, the correlation between MRI, single-photon
emission computed tomography (SPECT), and memory
impairment in the MCI group with higher alpha3/alpha2
frequency power ratio was investigated in order to detect a
prognostic value of this EEG biomarker.
Methods
Subjects
For the present study, 74 subjects with MCI were se-
lected from a prospective study on the natural history of
cognitive impairment (the translational outpatient mem-
ory clinic—TOMC study) carried out in the outpatient
facility of the National Institute for the Research and
Care of Alzheimer’s Disease (IRCCS Istituto Centro San
Giovanni di Dio Fatebenefratelli, Brescia, Italy). Patients
with MCI underwent clinical and cognitive assessment
and high-resolution MRI. A detailed description has
been provided elsewhere [12]. The study protocol was
approved by the local ethics committee, and all participants
or their caregivers signed an informed participation consent
according to the Code of Ethics of the World Medical As-
sociation (Declaration of Helsinki). The ethics committees
involved were from: 1) S. John of God Hospital, Brescia
(main committee); 2) Citta’ di Brescia’ Hospital, Brescia;
and 3) Ospedali Riuniti Hospital, Bergamo.
Diagnostic criteria
Patients were rated with a series of standardized diagnos-
tic and severity instruments, including the Mini-Mental
State Examination (MMSE) [13], the Clinical Dementia
Rating Scale (CDRS) [14], the Hachinski Ischemic Scale
(HIS) [15], and the Instrumental and Basic Activities of
Daily Living (IADL, BADL) [16]. Subjects also underwent
a complete neuropsychological battery assessing: memory
(Babcock Story Recall – Rey–Osterrieth Complex Figure,
Recall – Auditory-Verbal Learning Test, and immediate
and delayed recall), verbal and non-verbal memory, atten-
tion, and executive functions (Trail Making Test B, A and
B-A and Inverted Motor Learning-Clock Drawing Test;),
abstract reasoning thinking (Raven Colored Progressive
Matrices), frontal functions (Inverted Motor Learning),
language (Phonological and Semantic fluency-Token test),
and apraxia and visuo-constructional abilities (Rey–
Osterrieth Complex Figure, Rey figure copy, and Clock
Drawing Test) [17]. All the neuropsychological tests were
standardized on an Italian population, thus scores were
compared to normative values with age, education, and
gender corrections in an Italian population [18, 19].
In addition, patients underwent diagnostic neuroimag-
ing procedures [magnetic resonance imaging (MRI)] and
laboratory testing to rule out other causes of cognitive
impairment. MCI was defined as the presence of object-
ive impairment in memory or other cognitive domains
(performance lower than the fifth percentile on neuro-
psychological tests as detailed below) in the absence of
functional impairment. History or neurological signs of
major stroke, history of depression (from mild to moderate
or major depression) or juvenile-onset psychosis, other psy-
chiatric diseases, overt dementia, epilepsy, drug addiction,
or alcohol dependence, use of psychoactive drugs, including
acetylcholinesterase inhibitors or other drugs enhancing
brain cognitive functions or biasing EEG activity, and
current or previous uncontrolled or complicated systemic
diseases (including diabetes mellitus) or traumatic brain
injuries were absent. All subjects were right-handed. These
inclusion and exclusion criteria for MCI were based on
previous seminal studies [1]. As the aim of our study was
to evaluate the relationship between gray matter (GM) loss
and alpha2/alpha3 ratios in MCI subjects, we did not
consider the clinical subtype of MCI, i.e., amnesic or
non-amnesic, single or multiple domains. Demographic
and cognitive features of the subjects in this study are
summarized in Table 1. There were no statistically sig-
nificant differences in age, gender, or education among
the groups in this study.
Follow-up analysis
Table 2 shows the socio-demographical features of three
groups of patients that were obtained according to clinical
outcome after three years of follow-up: 1) MCI who did
not convert to any dementia; 2) MCI who converted to
AD; and 3) MCI who converted to dementia other than
AD [fronto-temporal spectrum (FTD), vascular dementia
(VD), or Lewy body dementia,(LBD)].
EEG recordings
The EEG activity was recorded continuously from 19 sites
by using electrodes set in an elastic cap (Electro-Cap
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International, Inc. Eaton, OH, USA) and positioned
according to the 10–20 international system. (Fp1,
Fp2, F7, F3, Fz, F4, F8, T3, C3, Cz, C4, T4, T5, P3, Pz,
P4, T6, O1, and O2). The patients were instructed to
sit with closed eyes and relax, constantly monitored by
an operator. The ground electrode was placed in front
of Fz. The left and right mastoids served as the refer-
ence points for all electrodes.
The recordings were used off-line to re-reference the
scalp recordings to the common average. Re-referencing
was done prior to the EEG artifact detection and ana-
lysis. A simple bimastoid referential derivation could
have the effect of distorting the EEG signal, introducing
spurious, non cerebral, activity. Data were recorded with
a band-pass filter of 0.3–70 Hz and digitized at a sam-
pling rate of 250 Hz (BrainAmp, BrainProducts, Munich,
Germany). Electrode-skin impedance was set below 5
kilo-ohms. Horizontal and vertical eye movements were
detected by electrooculogram (EOG). The recording lasted
5 min with the subjects eyes closed. EEG data were then
analyzed and fragmented off-line in consecutive epochs of
2 s with a frequency resolution of 0.5 Hz. The average
number of epochs analyzed was 140, ranging from 130 to
150. The epochs with ocular, muscular, and other types of
artifacts were discarded by two skilled electroencephalo-
graphists. The spectral power we obtained is an estimation
of a spectrum collapsed all over the scalp electrodes. In this
way, the eventual contribution of the muscular artifact is
strongly reduced. The spectral power was averaged across
all electrodes to obtain a sort of global field power, which
would have reduced the channel to channel variability, with
the advantage of extracting a high stationary measure
and of obtaining a smoother, clearer, and homogeneous
individual alpha peak [10]. Moreover, this method has
been chosen because it is not affected by the low spatial
resolution of EEG. It should be possible to compute a
more focused field, choosing a subset of electrodes next
to the brain region of interest. However, this procedure
has two main disadvantages: 1) it needs a larger array of
electrodes, given the volume conduction phenomenon. Of
note, a larger electrode array should require the applica-
tion of some further computation such as, for example,
Laplacian filter or spline interpolation; this aspect is of
particular importance because it is more time-consuming
and not applicable in a clinical context; and 2) the power
computation on a smaller number of electrodes could give
rise to artefactual detection of the individual alpha fre-
quency peak as the presence of double peak or the ab-
sence of a clear peak. These computation errors are
overlooked by the power spectra computation collapsed
on the whole array of electrodes. For the same reason,
i.e., the lack of information about EEG cortical generators
with conventional EEG, the correlation of structural or
metabolic data with a focal (or single) electrode array,
would give rise to poor information about the brain oscil-
lations in that point. Finally, the reason for the choice of a
global field power is the continuous interplay inside the
brain of different oscillation networks, so that it is an inte-
grated activity more than split focal loops. The reliability
of the relationship between a global field potential and the
underlying cortical activity has been recently demon-
strated by Brunet and colleagues [20]. On the other hand,
Table 1 Demographic and cognitive characteristics of the whole sample, disaggregated for increased levels of alpha3/alpha2
Alpha3/Alpha 2 power ratio
Demographic and clinical future High Middle Low p F
Number of subjects 18 38 18 — —
Age years 70.4 ± 6.7 [60-85] 68.4 ± 8.2 [52-83] 70.4 ± 7.4 [57-80] .55 0,6
Sex, female 13 (%) 24 (%) 14 (%) .51 0,67
Education, years 6.6 ± 3.6 [4–18] 7.6 ± 3.7 [3–17] 8.3 ± 4.7 [3–18] .42 0,89
Mini Mental State Exam 27 ± 1.7 [23–29] 27.4 ± 1.3 [24–30] 26.9 ± 1.2 [23–30] .46 2,46
Alpha3/alpha2 1.29 ± 0.1 [1.17-1.52] 1.08 ± 0.0 [1-1.16] 0.9 ± 0.1 [0.77-0.98] .000 144,62
Numbers denote mean ± standard deviation, number and [range]. p denotes significance on analysis of variance (ANOVA)
Table 2 ANOVA results of demographic variables, i.e., age, education, MMSE score, and alpha3/alpha2 ratio (see text for details)
Demographic and clinical features MCI cohort MCI NON CONVERTERS MCI AD CONVERTERS MCI NON-AD CONVERTERS p value (ANOVA)
Number of subjects (f/m) 74 (46 F/28 M) 42 (30/14) 18 (10/8) 14 (7/7)
Age (years) 69.7 ± 2.3 69.4 ± 4.1 71.8 ± 5.7 70.1 ± 3.9 0.1
Education (years) 7.4 ± 0.8 7.3 ± 2.5 8.4 ± 3.1 8.8 ± 4.6 0.4
MMSE 26.8 ± 1.4 27.2 ± 1.4 25.7 ± 1.5 26.8 ± 1.8 0.001
alpha3/alpha2 ratio 1.15 ± 0.2 1.14 ± 0.3 1.26 ± 0.5 1.03 ± 0.7 0.02
The values are all intended at baseline. ANOVA analysis of variance, MMSE Mini-Mental State Examination, MCI mild cognitive impairment, AD Alzheimer’s Disease
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it should be advisable that further studies confirm these
results obtaining a more detailed spatial resolution with
some other methods, such as LORETA (low resolution
electromagnetic tomography). With the aim of verifying
the reliability of our collapsed method, we evaluated the
correlation of the total alpha frequency band of global field
power with the same alpha frequency in two macroareas,
the frontotemporal and the parietoccipital regions. The
Pearson’s correlation resulted in positive high correla-
tions of, respectively 0.85 (p < 0,005) and 0.91 (p < 0,001).
Analysis of individual frequency bands
All recordings were obtained in the morning with subjects
resting comfortably. Vigilance was continuously monitored
in order to avoid drowsiness. A digital FFT-based power
spectrum analysis (Welch technique, Hanning windowing
function, no phase shift) computed the power density of
EEG rhythms (ranging from 2 to 45 Hz) with a 0.5 Hz fre-
quency resolution. Two anchor frequencies [the theta/alpha
transition frequency (TF) and the individual alpha fre-
quency (IAF) peak] were selected according to the literature
guidelines [21]. IAF and TF were computed for each sub-
ject in the study. These anchor frequencies were computed
on the power spectra averaged across all recording elec-
trodes. This “collapsed spectrum method,” being a normal-
ized scalp spectrum, allows for the identification of a robust
and reliable IAF. As a consequence, the computation of an
individual alpha frequency peak was mandatory for our
study. The TF marks the transition frequency between the
theta and alpha bands and represents an estimate of the fre-
quency at which the theta and alpha spectra intersect. TF
was computed as the minimum power in the alpha fre-
quency range since our EEG recordings were performed at
rest. The IAF represents the frequency with the maximum
power peak within the extended alpha range (5–14 Hz).
Based on TF and IAF, we estimated the frequency band
range for each subject as follows: delta from TF-4 to TF- 2,
theta from TF-2 to TF, low alpha band (alpha1 and alpha2)
from TF to IAF, and high alpha band (or alpha3) from IAF
to IAF + 2. The alpha1 and alpha2 bands were computed
for each subject as follows: alpha1 from TF to the midpoint
of the TF-IAF range, and alpha2 from this midpoint to the
IAF peak. The mean frequency range computed in MCI
subjects considered as a whole are: delta 2.9–4.9 Hz; theta
4.9–6.9 Hz; alpha1 6.9–8.9 Hz; alpha2 8.9–10.9 Hz; alpha3
10.9–12.9 Hz. Finally, in the frequency bands determined
on an individual basis, we computed the relative power
spectra for each subject. The relative power density for each
frequency band was computed as the ratio between the ab-
solute power and the mean power spectra from 2 to 45 Hz.
The alpha3/alpha2 was computed in all subjects and three
groups were obtained according to increasing tertile values
of alpha3/alpha2: low (a3/a2 < 1;) middle (1 < a3/a2 < 1.16)
and high (a3/a2 > 1.17). The tertile division allows a
balanced distribution of the study samples with the advan-
tage of avoiding the extreme value in the statistical analysis.
The three groups of MCI have been shown in previous
studies to be different in nature. In particular, the high
alpha3/alpha2 EEG power ratio MCI group is at major
risk to convert to Alzheimer’s disease [11] compared
to the other alpha3/alpha2 power ratio MCI groups.
Moreover, we utilized this group subdivision for homogen-
eity and comparability with the previous studies.
MRI scans
For each subject, a high-resolution sagittal T1 weighted
volumetric MR scan was acquired in the Neuroradiology
Unit of the ‘Citta’ di Brescia’ Hospital, Brescia, by using
a 1.0 T Philips Gyroscan scanner with a gradient echo
3D technique: TR = 20 ms, TE = 5 ms, flip angle = 30, field
of view = 220 mm, acquisition matrix 256 x 256 mm, slice
thickness 1.3 mm.
Cortical thickness estimation steps
Cortical thickness measurements for 74 MCI patients
were made using a fully automated magnetic resonance
imaging-based analysis technique: FreeSurfer v5.1.0, a
set of software tools for the study of cortical and subcor-
tical anatomy. Briefly, in the cortical surface stream, the
models of the boundary between white matter and cortical
gray matter, as well as the pial surface, were constructed.
Once these surfaces are known, an array of anatomical
measures becomes possible, including cortical thickness,
surface area, curvature, and the surface normal at each
point on the cortex [22].
Single subject analysis
For each subject, the T1-weighted, anatomical 3-D MRI
dataset was converted from Dicom format into .mgz for-
mat, intensity variations were corrected, and a normalized
intensity image was created. The volume was registered
with the Talairach atlas through an affine registration.
Next, the skull was stripped using a deformable template
model [22], and extracerebral voxels were removed. The
intensity was normalized, and the skull-stripped image
was then operated on by a segmentation procedure based
on the geometric structure of the gray–white interface.
Voxels were classified as white or gray matter, and cutting
planes were selected to separate the hemispheres from
each other. A white matter surface was then generated for
each hemisphere by tiling the outside of the white matter
mass for that hemisphere. Cortical thickness measure-
ments were obtained by calculating the distance between
those surfaces (white and pial surfaces) at each of approxi-
mately 160,000 points per hemisphere across the cortical
mantle [22].
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Group analysis
In order to relate and compare anatomical features across
subjects, it was necessary to establish a mapping that spe-
cifies a unique correspondence between each location in
one brain and the corresponding location in another.
Thus, the pial surface of an individual subject was inflated
to determine the large-scale folding patterns of the cortex
and subsequently transformed into a sphere to minimize
metric distortion. The folding patterns of the individual
were then aligned with an average folding pattern using a
high-resolution surface-based averaging. Thickness mea-
sures were mapped to the inflated surface of each partici-
pant’s brain reconstruction, allowing visualization of data
across the entire cortical surface. Finally, cortical thickness
was smoothed with a 20-mm full-width at half-height
Gaussian kernel to reduce local variations in the measure-
ments for further analysis [22].
Statistical analysis
Differences between groups in sociodemographic and
neuropsychological features were analyzed using SPSS
version 13.0 (SPSS, Chicago, IL, USA) performing an
analysis of variance (ANOVA) for continuous variables
and paired χ2 test for dichotomous variables. For continu-
ous variables, post-hoc pairwise comparisons among groups
were performed with the Games-Howell or Bonferroni
tests, depending on the homogeneity of variance tested
with Levene’s test.
Concerning the neuroimaging analysis, the Qdec inter-
face in Freesurfer software was used. A vertex-by-vertex
analysis was carried out performing a general linear model
to analyze whether any difference in mean cortical thick-
ness existed between groups (low: a3/a2 < 1 μV2; middle:
1 < a3/a2 < 1.16 μV2; high: a3/a2 > 1.17 μV2). The follow-
ing comparisons were carried out: High vs. Low, High vs.
Middle, and Middle vs. Low. Age, sex, education, global
cognitive level (MMSE score), and WMHs were intro-
duced as covariates in the analysis to avoid confounding
factors. We first tried to apply an appropriate Bonferroni
multiple-comparison correction in our analysis (at p < 0.05
corrected). Unfortunately, no p-value survived after this
correction. Thus, we choose to set a more restrictive sig-
nificance threshold (than p < 0.05 corrected) at p < 0.001
uncorrected for multiple comparisons. Moreover, we
considered as significant only the clusters that also
were equal to or larger than 30 mm2. Finally, a surface
map was generated to display the results on an average
brain. For illustrative purposes, significance was set to a
P-value of ≤0.01 uncorrected for multiple comparisons.
As a control analysis, in order to exclude casual rela-
tionships between EEG markers and cortical volumes, a
correlation between brain areas and memory performance
was examined. The correlation analysis was performed
on the three samples separately (High a3/a2, Low a3/a2,
Middle a3/a2) and the entire sample (High, Low, and
Middle grouped together). An exploratory analysis of
non-linear correlation did not fit into the purpose of
testing our a priori hypothesis. Indeed, we choose to apply
a measure of linear dependence led by our a priori hy-
potheses for which the MCI group with the greater
cortical thinning and higher a3/a2 EEG level (indicating an
incipient AD) should show a clear correlation with the
memory tests performance, in the sense that an increase in
cortical thinning corresponds to a decrease in memory per-
formance, and vice versa. Indeed, even if in the cognitive
tests scores there are no significant differences, we hypothe-
sized that the MCI group with the greater cortical thinning
and higher a3/a2 EEG level, indicating an incipient AD,
should show a clear correlation with the memory tests per-
formance. The correlation analysis on a vertex-by-vertex
basis was performed specifically for the following neuro-
psychological memory test results: Babcock Test, Rey audi-
tory verbal learning test (AVLT) immediate recall, and
Rey AVLT delayed recall. The analysis was thresholded
at p < 0.001 uncorrected for multiple comparisons while
results were mapped at P-value of <0.005 uncorrected
for illustrative purposes. Only the clusters that survived
at the statistical threshold and were equal to or larger
than 15 mm2 were considered as significant.
Statistical follow-up analysis
Preliminarily, one-way ANOVAs were performed in order
to verify that the alpha3/alpha2 relative power ratio was
significantly different among groups.
Finally, a discriminant factor analysis was performed to
verify if the same significant variables could be useful in
discriminating subjects and could have a diagnostic value.
The model was built as follows: variable selection was
done with a stepwise method; tolerance was set to 0.01
and F to enter to 1,0.
SPECT scan
Twenty-seven patients and 17 normal controls underwent
a SPECT scan in the nuclear medicine department of the
Ospedali Riuniti Hospital, Bergamo. Each subject received
an intravenous injection of 925 MBq of technetium-99 m
ethyl cysteinate dimer (99mTc-ECD) in resting conditions,
lying supine with eyes closed in a quiet, dimly lit room.
Forty to sixty minutes after injection, brain SPECT was
performed using a dual-head rotating gamma camera
(GE Elscint Helix, Wauwatosa, WI, USA) equipped with
low energy-high resolution, parallel hole collimators. A
128 × 128 pixel matrix, zoom = 1.5, was used for image ac-
quisition with 120 views over a 360° orbit (in 3° steps) with
a pixel size and slice thickness of 2.94 mm. Butterworth
filtered-back projection (order = 7, cutoff = 0.45 cycles/cm)
was used for image reconstruction and attenuation correc-
tion was performed using Chang’s method (attenuation
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coefficient = 0.11/cm). Images were exported in DICOM
format.
SPECT processing protocol
To achieve a precise normalization, we generated a study-
specific SPECT template using both SPECT and MR scans
of all patients and normal controls under study following
a procedure described in detail elsewhere [21]. Briefly, we
created a customized high-definition MR template, we
converted SPECT scans to Analyze format using MRIcro
(Columbia, SC, USA), and we coregistered them to
their respective MR scans with SPM2 (SPM, Statistical
Parametric Mapping, version 2; Functional Imaging La-
boratory, London, UK). We normalized each MR to the
customized MR template through a nonlinear transform-
ation (cutoff 25 mm) and applied the normalization
parameters to the coregistered SPECT. We obtained
the customized SPECT template as the mean of all the
latter normalized SPECT images. The creation of a
study-specific template allows for better normalization
since it accounts for low uptake in ventricular struc-
tures and cortical hypoperfusion effects frequently
present in elderly patients. The following regions of
interest (ROI) were chosen for perfusion analyses in
each hemisphere from the Pick atlas by a sub-routine
implemented on SPM2: frontal, parietal and temporal
lobes, the thalamus, and the hippocampal-amygdalar
complex [23].
SPECT statistical analysis
All statistical analyzes were performed using SPSS soft-
ware ver. 13.0. We investigated the significance of the
difference between the two groups (MCI at low and at
high risk to develop AD) in socio-demographic, clinical,
and cognitive features using the χ2 test for categorical
variables (sex and ApoE carriers) and Student’s inde-
pendent t test for continuous variables (volumetric, per-
fusion features, and EEG frequencies). In all cases, we
set the significance threshold at p < 0.05. Since native
SPECT scans were coregistered to their respective MR
images, and the study-specific SPECT template was
coregistered to the high-definition MR template, all
the normalized SPECT and MR images used for the
statistical analysis were coregistered to the SPM standard
anatomical space. Pearson’s r correlations were assessed
between the selected perfusion ROI (in terms of age




Table 1 shows the sociodemographic and neuropsycho-
logical characteristics of MCI subgroups defined by the
tertile values of alpha3/alpha2. The ANOVA analysis
showed that there were no statistically significant differ-
ences between groups which paired for age, sex, white mat-
ter hyperintensities (WMHs) burden, education, or global
cognitive level. In addition, age, sex, education, global cog-
nitive level (MMSE score), and WMHs were introduced as
covariates in the subsequent analysis to avoid confounding
factors. Alpha3/alpha2 ratio levels were significant using
Games-Howell post hoc comparisons (p < 0.0001).
Pattern of cortical thickness between groups
i. High vs Low: When compared to subjects with low
a3/a2 ratios, patients with high a3/a2 ratio show
thinning of the bilateral superior temporal,
supramarginal, and precuneus cortices, in the right
inferior parietal cortex and insular cortex. The total
cortical gray matter (CGM) reduction in the high
a3/a2 group compared to the low a3/a2 group was
471 mm2 (Fig. 1).
ii. High vs Middle: The same group showed a similar
but less wide pattern of cortical thinning when
compared to the middle a3/a2 group: the regions of
atrophy were located in the left supramarginal gyrus,
left precuneus, and postcentral cortex. The total
CGM reduction in the high a3/a2 group compared
to the middle a3/a2 group was 160 mm2 (Fig. 2).
When the high group was compared to the low
group, the total extent of cortical thinning
(471 mm2) was 34 % larger than in the comparison
of the high group to the middle group (160 mm2).
No regions of major cortical atrophy were found in
groups with middle or low a3/a2 power ratio when
compared to the high a3/a2 group. No significant
cortical thickness differences were found between
middle and low a3/a2 groups.
Correlations between neuropsychological memory tests and
cortical thickness in the high a3/a2 group and other groups
1) Babcock Test: In the high alpha3/alpha2 group, a
significant positive correlation was found between
logical memory performance in the Babcock test and
thickness values in the left caudal middle frontal
cortex (cluster size = 36 mm2; stereotaxic coordinate
x, y, z = −34 22 47; r = 0.80; p = 0.0001) and left
inferior temporal cortex (15 mm2; −54 -28 -26;
r =072; p =0001), and right rostral middle frontal
cortex (28 mm2; 23 56–13; r = 0.74; p = 0.00)
(Fig. 3). No significant correlation was found within
the same regions nor in the other groups nor in the
whole sample. 2) AVLT immediate recall: In the
high alpha3/alpha2 group, memory performance was
significantly correlated with the cortical thickness
values in the precuneus bilaterally (left 47 mm2; −21
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Fig. 1 In red are represented the brain regions with higher regional cortical thickness in MCI patients with high a3/a2 ratio as compared to MCI
patients with low a3/a2 ratio (p < 0.01 uncorrected). The color-coding for p values is on a logarithmic scale. Results are presented on the pial cortical
surface of the brain: dark gray regions represent sulci and light gray regions represent gyri. MCI mild cognitive impairment
Fig. 2 In red are represented the brain regions with higher regional cortical thickness in MCI patients with high a3/a2 ratio as compared to MCI
patients with middle a3/a2 ratio (p < 0.01 uncorrected). The color-coding for p values is on a logarithmic scale. Results are presented on the pial
cortical surface of the brain: dark gray regions represent sulci and light gray regions represent gyri. MCI mild cognitive impairment
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-61 ; r = 0.78 < 0.000, right 58 m2; 20–60 25; r = 0.72
= 0.007, left fusiform cortex (40 mm2; −41 -25 -21;
r = 0.76; p = 0005), inferior infertile parietal 43 mm2
-46 -60 11; r = 0.74; p = 0.0001), inferior temporal
cortex (35 mm2; 21; r = 0.71; p = 0.0008), and the
right bank of the superior temporal sulcus (44 m8 9;
r = < 0.000). Memory performance was correlated in
the middle group with both the right precuneus
cortex (r = 0 = 0.03), and banks of the superior
temporal sulcus (r = 0..02). No other associations
were found in either the low group or in the entire
sample.
3) AVLT delayed recall: In the high alpha3/alpha2
group, memory function correlated significantly
with cortical thickness in the inferior parietal cortex
bilaterally (left: 95 mm2; −44 -58 12; r = 0.86;
p < 0.0000; right: 49 mm2; 50–50 9; r = 0.74;
p = 0.0005), left pericalcarine cortex (54 mm2; −7 -8 11;
r = 0.76; p < 0.0000), the banks of the superior temporal
sulcus (31 mm2; −51 -41 -5; r = 0.81; p = 0.0002), and
in the right superior temporal cortex (22 mm2; 56–34
13; r = 0.73; p = 0.001) . No significant correlation was
found within the same regions in the other groups or
in the whole sample.
SPECT
Twenty seven MCI patients were enrolled in the present
study and classified as at high risk (when the a3/a2 EEG
rhythm median was above 1.17; N = 13) or at low risk
(when the a3/a2 EEG rhythm median was under 1.17;
N = 14) to develop AD. The two groups were similar in
age (p = 0.56), education in years (p = 0.87), gender (p =
0.17), ApoE genotype (p = 0.15), MMSE scores (p = 0.31),
and white matter lesions load (p = 0.88; Table 3). Figure 3
shows the visual rating scale of the SPECT scans represen-
tative of normal control, MCI with low risk to convert to
AD, and MCI with high risk to convert to AD. ANOVA
results show that the selected cut-off was effective in
Fig. 3 SPECT visual rating. The output shows a SPECT visual inspection of glucose uptake metabolism: the black square denotes an area of
mild-to-moderate temporo-parietal hypometabolism in one of the 14 low risk MCI patients and in one of the 13 high risk MCI patients respective
to one of the 17 enrolled controls. SPECT single-photon emission computed tomography, MCI mild cognitive impairment
Table 3 Demographic and cognitive characteristics of the SPECT subjects sample, disaggregated for increased levels of
alpha3/alpha2
Demographic and clinical features At low-risk At high-risk p
MCI MCI
Number 14 13
Age (years) [Range] 69.1 ± 7.6 [57÷83] 70.6 ± 5.5 [62÷78] 0.555
Gender (females) 6 (43 %) 9 (69 %) 0.168
Education (years) [Range] 8.2 ± 4.3 [4÷18] 7.9 ± 4.5 [3÷18] 0.865
MMSE score [Range] 27.9 ± 1.6 [25÷30] 27.2 ± 1.9 [24÷29] 0.309
ApoE ε4 genotype (carriers) 2 (29 %) 5 (39 %) 0.152
Left hippocampal volume (mm3) [Range] 2,606 ± 353 [1,923÷3,017] 2,073 ± 412 [1,234÷2,641] 0.001
Right hippocampal volume (mm3) [Range] 2,581 ± 473 [1,549÷3,150] 2,296 ± 501 [1,589÷3,086] 141
Wahlund total score [Range] 3.58 ± 3.29 [0.0÷10.0] 3.78 ± 2.63 [0.0÷7.0] 0.886
Numbers denote mean ± standard deviation, number and [range]. p denotes significance on ANOVA
SPECT single-photon emission computed tomography, MCI mild cognitive impairment, MMSE Mini-Mental State Examination, ApoE apolipoprotein E
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detecting two different groups: patients with high risk
to develop AD show significantly higher alpha3/alpha2
power ratio than patients with low risk (p = 0.0001).
Moreover, a control analysis was performed on the single
frequencies. The results show that the increase of alpha3/
alpha2 frequency power ratio was due to both increase of
alpha3 (p = 0.001) and decrease of alpha2 (p = 0.0001) and
not to the modification of a single frequency. This control
analysis was performed because the change of only
one frequency could be due to chance, but this was not
the case.
Of note, no differences were found for beta 1, beta 2,
gamma, theta EEG power, or theta/gamma frequency
power ratio (all p > 0.11). Although the mean perfusion
in all the selected ROIs was similar between groups (all
p > 0.38), in the group with high alpha3/alpha2 frequency
ratio, there is a constant trend to a lower perfusion. More-
over, left hippocampal volumes were lower for AD-high
risk patients compared to low-risk patients (p = 0.001).
In patients at low risk to develop AD, a significant
Pearson’s r negative correlation was found between
perfusion in the hippocampal complex ROI and theta
rhythm (r = −0.544, p = 0.044).
In patients at high risk to develop AD, other correla-
tions were found. In contrast to patients at low risk, we
found a positive correlation between perfusion in the
hippocampal complex ROI and theta rhythm (r = 0.729,
p = 0.005) in high risk patients while temporal ROI cor-
related positively with theta/gamma ratio rhythms (r =
0.736, p = 0.004) in this group. No other significant cor-
relations were found in either group between perfusion
ROIs and other EEG rhythms or hippocampal volumes.
Moreover, no significant correlations were found be-
tween hippocampal complex ROI and theta rhythm
pooling in low and high-risk patients together (r = 0.086,
p = 0.671).
Correlations between neuropsychological memory tests and
regional brain perfusion in the high a3/a2 group and other
groups
1) Babcock Test: In the high alpha3/alpha2 group, a
significant positive correlation was found between
logical memory performance in the Babcock test and
lower perfusion values in precuneus bilaterally (0.63
p = 0.03;) and superior temporal sulcus bilaterally
(r = 0.74, p = 0.005). Moreover, a positive correlation
was also found with hippocampal atrophy (r = 0.75,
p = 0.001).
2) AVLT immediate recall: In the high alpha3/alpha2
group, memory performance was significantly
correlated with lower perfusion values in the caudal
bank of the right inferior temporal sulcus and
middle frontal gyrus ( r = 0.75, p = 0.003).
3) AVLT delayed recall: In the high alpha3/alpha2
group, memory function correlated significantly with
lower perfusion values in the inferior parietal lobule,
particularly in the supramarginal gyrus (r = 0.09,
p = 0.05).
Follow-up results
Figure 4 showed ANOVA significant statistical difference
of theta/gamma and alpha3/alpha2 relative power ratio
(F2,73 = 3.70; p < 0.03 and F2,73 = 4.46; p < 0.02, respect-
ively). Duncan’s post-hoc test showed a significant increase
(p < 0.01) of theta/gamma in both the MCI converters
group with respect to non-converters as well as a significant
increase of alpha3/alpha2 ratio in the MCI-AD converters
with respect to the other groups (p < 0.02). In order to
strengthen the results, the analysis was repeated also
covarying the hippocampal volume and neuropsycho-
logical tests (NPS) scores. Significant results were
Fig. 4 ANOVA results of theta/gamma and alpha3/alpha2 relative power ratio. In the graph post-hoc results are shown (see text for details).
ANOVA analysis of variance
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confirmed for both theta/gamma (F2,73 = 2.49; p < 0.05)
and alpha3/alpha2 ratio (F2,73 = 3.15; p < 0.04).
The results of discriminant factor analysis show a
statistically significant result for the model (F30,185 = 11.16;
p < 0.00001; Wilks Lambda 0.04). A correct classification of
groups was performed in the 85 % of cases in the first
group, in the 94 % in the second group, and in the 86 % in
the third group. The mean correct percentage of correct
classification was 88.3 %. Based on the model structure,
the variables accepted, ordered for statistical significance,
were: theta/gamma frequency ratio (p < 0.0003) and alpha3/
alpha2 frequency ratio (p < 0.03). EEG markers, together
with duration of disease, were the most powerful variables
in discriminating groups. The canonical analysis shows that
the variables accepted were arranged in two discriminant
functions (or roots). The two roots were all statistically sig-
nificant (root1, p < 0.0001, root2, p < 0.001). Figure 5 shows
a scatterplot of canonical scores (root1 vs. root2). The fac-
tor loadings of the variables on each discriminant function,
as addressed by the factor structure matrix, shows that in
root1 the theta/gamma relative power ratio has positive
(0.5), and alpha3/alpha2 relative power ratio has negative,
correlations (−0.7) whereas in root2 the theta/gamma rela-
tive power ratio has negative, (−0.6) and alpha3/alpha2 rela-
tive power ratio has positive (0.8), correlations with the
discriminant function. As a consequence, an increase of
theta/gamma relative power ratio better identifies the third
group, and the increase of alpha3/alpha2 relative power ra-
tio better identifies especially the second group.
Discussion
Study limitations
It needs to be remarked that our results about the EEG
biomarker alpha3/alpha2 relative power ratio could have
been emphasized given that a single class of dementia is
considered. Of note, a recent study has demonstrated that
the predictive value as well as the clinical application of
the EEG biomarkers has to be proved in studies encom-
passing different forms of dementia [24]. Moreover, it
should be pointed out that in our electrode array FP3,
FP4, and inferotemporal zygomatic electrodes, which
could provide information on hippocampal activity, were
not present. This aspect could have limited the data col-
lected in the study. However, the main scope of the study
was the recording and analysis of cortical activity, fully
mirrored by the electrode array utilized in the present
study.
Association between EEG markers and gray matter
changes
In the present study, the relationship between an EEG
marker (the alpha3/alpha2 power ratio) and the cortical
thickness in subjects with MCI was investigated. The
alpha3/alpha2 power ratio was selected because previous
work has demonstrated that MCI subjects with a higher
alpha3/alpha2 ratio are at major risk of developing AD
[25–29]. Our results show that the MCI group with the
higher alpha3/alpha2 ratio has a greater global cortical
atrophy than the other subgroups, thus confirming a
large body of literature [25–31]. Furthermore, the greater
atrophy is significant in two specific brain areas: the precu-
neus and the supramarginal gyrus (a brain area belonging
to the inferior parietal lobule), on both the left and right
hemispheres. These results were largely expected consider-
ing previous studies. Indeed, structural and functional ab-
normalities of the precuneus were observed in MCI [32] as
well as in AD [33] so that atrophy of the precuneus has
been considered a pathognomonic marker of early AD.
Association between EEG markers and perfusional
changes
These results confirm previous studies that have shown
that patients at high risk of developing AD have reduced
SPECT perfusion in the temporo-parietal cortex and
Fig. 5 Discriminant factor analysis results: root1 vs root2 (see text for details)
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inferior parietal lobule [21]. The present study shows a
correlation between cerebral perfusion and theta rhythm.
However, the correlation emerges only when considering
the different groups individually using the alpha3/alpha2
frequency power ratio. This is confirmed by the finding
that when the groups are merged, no correlation could be
found. This is the main aspect of the study and the pecu-
liar novelty of the results. The patients at lower risk to de-
velop AD, who have a constant trend towards a higher
brain regional blood perfusion, maintain low levels of hip-
pocampal theta power while in patients at higher risk, with
a basically lower cerebral blood perfusion, theta rhythm
tends to be higher in the hippocampus. Theta rhythms are
usually not appreciated in normal awake EEGs. However,
a theta power increase is observed over the frontal and
temporal areas during learning and memory tasks [34].
The theta rhythms that are recorded during these tasks
are thought to be produced by the activation of the septal-
hippocampal system. The hippocampus has a cholinergic
innervation originating from the basal forebrain, the med-
ial septum, and the vertical limb of the diagonal band of
Broca. Populations of GABAergic and glutamatergic neu-
rons have also been described in several basal forebrain
structures. The synchronized depolarization of hippocam-
pal neurons produces field potentials that have a main fre-
quency of 3–12 Hz and are usually known as hippocampal
theta rhythm [34]. A cholinergic-glutamatergic hypothesis
of AD, in which cholinergic-glutamatergic deficits may
explain most symptoms, has been advanced. Neuronal
injury/loss may include an excitotoxic component that
possibly contributes to the early cholinergic deficit. This
excitotoxic component may occur, at least in part, at the
septal level where the somas of cholinergic neurons are
found. This insult may modify septal networks and con-
tribute to the abnormal information processing observed
in AD brain, including its hyperexcitability states.
Neurophysiological implications
Recent studies have demonstrated that during the success-
ful encoding of new items, there is a desynchronization in
the temporo-parietal memory-related networks, whereas
synchronization prevents a successful semantic encoding
[35]. The deleterious role of synchronization has been
recently demonstrated by an interesting study of the in-
triguing relationship between functional and structural
degeneration in AD. The authors detected some hub
regions (heteromodal associative regions) with selective
vulnerability to AD pathology due to the damage of in-
hibitory interneurons providing a loss of inhibition at
the cellular level. According to the authors, the disin-
hibition provokes an increasing amount of neural activ-
ity at the network level, giving a hypersynchronization
of brain areas as a final result. Of note, this overactivity
is excitotoxic and determines cellular apoptosis and
brain atrophy [36]. Also, Palop and Mucke emphasize
the role of inhibitory interneuron dysfunction leading
to hypersynchronization [36]. Our results are in line
with these previous influential studies. A possible inte-
grative view of all the results could be as follows: 1) the
higher neuronal activity in the hub regions starts from
a dysfunction of cellular inhibition; 2) the consequent
disinhibition drives the neural network to an oversyn-
chronization; 3) this oversynchronization is unique to
the hub regions with higher amyloid burden; 4) these
overactivated regions are prone to degeneration and at-
rophy; and 5) a possible neurophysiological sign of this
oversynchronization is the increase of the alpha3/alpha2
power ratio we have found in typical hub regions [37–40].
It is of great interest that there is an overlap between the
brain regions associated with the increase of the EEG
alpha3/alpha2 power ratio (hypersynchronization of upper
alpha) in our study and the regions associated with higher
amyloid burden related to memory processes [41]. More-
over, in the present study, it is interesting that the atrophy
of the precuneus is coupled with atrophy in the supramar-
ginal gyrus and, to a lesser extent, the inferior parietal
cortex, insula, and superior temporal gyrus. This atrophy
pattern is clearly expressed in the group of MCI subjects
with a higher alpha3/alpha2 power ratio. This finding fits
well with the results of a recent study investigating the
functional connectivity of human precuneus by resting
state fMRI [41]. The authors found that there was a pref-
erential pathway of connectivity of the dorsal precuneus
with the supramarginal gyrus, parietal cortex, superior
temporal gyrus, and insula. Consequently, the atrophy we
detected in the MCI group with higher alpha3/alpha2
power ratio could be hypothesized as the loss of GM in an
entire anatomo-functional network as opposed to atrophy
of isolated brain areas. Of note, it is widely accepted that
AD is the result of a cortical network impairment more
than the atrophy of single cortical areas [41].
Memory performance
In order to exclude a random relationship between EEG
markers and cortical atrophy, the correlation between brain
areas and the performance on memory tests was investi-
gated in all MCI subgroups. The memory tests were se-
lected because of their well-known greater impairment in
MCI subjects who will convert to AD [1]. Our results show
no significant memory differences among the groups. This
could be a paradoxical outcome. However, it could not
be considered a surprising result, taking into account the
globally mild and early impairment of the whole group of
subjects. In other words, when considering strictly the
memory performance, the groups are not different. This is
probably due to the early and mild cognitive impairment.
However, despite no significant differences in the memory
test scores, when focusing on the relationship between
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memory performance and a reliable structural marker,
such as the cortical thickness, the MCI group with the
higher alpha3/alpha2 power ratio has shown a (negative)
correlation between memory test performance and the
cortical thickness, as expected in patients with probable
prodromal AD. This result confirms the peculiar nature of
this MCI group, showing a clear specificity concerning
both the cortical atrophy and the correlated memory
performance. Moreover, no other socio-demographical or
structural differences were observed in the MCI groups
that could explain the correlation analysis results. The
cortical areas associated with cortical thinning and those
correlated with memory test performances are only partly
overlapping. This could be due to the particular nature of
the memory domain, underpinning a large number of
brain areas. On the other hand, MCI subjects more sus-
ceptible to convert to AD could also show impairment in
other cognitive domains, such as visuospatial attention or
execution and preparation of spatially guided behavior
[41]. Of note, the cortical network encompassing precu-
neus and inferior parietal cortex is deeply involved in
visuospatial abilities and left hippocampal atrophy [41]. As
a speculative interpretation, we could hypothesize that the
memory deficits are due to an impaired network under-
lying the semantic coding of the spatial features of the epi-
sodic memory traces. In this view, the atrophy of a specific
brain network (more than global volume measures) is
more reliable in detecting MCI subjects with prodromal
AD. However, the discussion of memory-related brain net-
works is beyond the scope of the present study. Only a
weak negative correlation was found in the middle alpha3/
alpha2 EEG power ratio group, suggesting a possible
degenerative nature of the memory impairment in this
group. No significant associations were found in the low
alpha3/alpha2 power ratio group and the whole sample.
Taken together, these results strengthen the position of
the higher alpha3/alpha2 ratio MCI group as being at
major risk of developing Alzheimer’s disease.
Diagnostic implications
After three years of follow-up, three subgroups were
characterized as converters to Alzheimer’s disease (AD,
N = 18), converters to non-AD dementia (N = 14) and
non-MCI to AD converters (N = 42). Increased alpha3/
alpha2 ratio was only associated with conversion to AD.
EEG markers allow a mean correct percentage of correct
classification up to 88.3 %. Future prospective studies are
needed to evaluate the sensitivity and specificity of these
measures for predicting an AD outcome.
Implications at the system level
Klimesch and coworkers have convincingly demonstrated
that the upper alpha band (10–13 Hz) specifically re-
flects encoding memory processes [42]. Recent EEG
and magnetoencephalography (MEG) studies have con-
firmed that a correct functioning of memory, both in
encoding and in retrieval, requires a high alpha rhythm
desynchronization (or power decrease) [42]. From a
neurophysiological point of view, the synchronization
(or power increase) of EEG alpha power has been associ-
ated with the inhibition timing hypothesis [43] and with
poor information transmission, according to the entropy
theory [44]. Applying this concept to the neural networks,
it has been demonstrated that the degree of information
that is encoded in neural assemblies increases as a func-
tion of desynchronization and decreases as a function of
synchronized firing patterns This hypothesis has been
confirmed in clinical studies in patients with memory defi-
cits [45] as well as during states where there is little cogni-
tive processing (e.g., epileptic seizures or slow wave sleep)
[46]. Concerning cognitive impairment due to AD, the
typical synaptic losses could prevent the physiological
flexibility of brain neural assemblies, impeding the desyn-
chronizing downstream modulation of the brain activity.
Therefore, it could be hypothesized that the disruption of
the cortical network due to degenerative disease, inducing
cortical atrophy, could determine an oversynchronization
of the brain oscillatory activity. The synchronization state
of the high alpha power could prevent the creation of a se-
mantic sensory code and, consequently, of the episodic
memory trace. Of note, according to the new diagnostic
criteria for AD, the measurement of sensitivity to semantic
cueing can successfully differentiate patients with AD
from healthy controls, even when patients are equated to
controls on MMSE scores or when disease severity is very
mild. Our results are in line with this hypothesis, suggest-
ing that an increase in the power of high alpha brain oscil-
lations reflects a block of information processes. However,
the present study goes one step further, linking the in-
crease of high alpha synchronization to the atrophy of a
specific brain network, correlated with impairment in
memory performances and decreased cerebral blood flow
activity.
Preliminary remarks
There are some limitations and caveats in the present
study: (1) further studies are needed to confirm our re-
sults on larger samples and to apply appropriate multiple
comparison corrections; (2) the pattern of cortical thickness
should be investigated on the remaining EEG frequency
measures; (3) the conservative p < 0.001 used here is not
necessarily sufficient given the number of comparisons.
Given the explorative nature of the study it is plausible
to use a permissive approach in order to avoid the rejec-
tion of possibly interesting results. It remains clear that
further studies with a less permissive statistical approach
are mandatory to confirm our results. Of note, the reliabil-
ity of the results is supported by: (1) the rigorous selection
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criteria of the subjects; (2) the high statistical threshold (p
< 0.001) considered; (3) the large size of pixel accounted
for the analysis (30 mm2); and (4) finally, the statistical
control analysis represented by the correlation of cortical
thickness with memory tests.
Conclusions
A high EEG upper/low alpha power ratio was associated
with cortical thinning and lower perfusion in the
temporo-parietal lobe. Moreover, atrophy and lower per-
fusion rate were both significantly correlated with mem-
ory impairment in MCI subjects. The increase in the
upper/low alpha frequency power ratio could be useful
for identifying individuals at risk for progression to AD
dementia and may be of value in the clinical context.
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